Apoorva O. Rajan-Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Apoorva O. Rajan-Sharma has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Maki
Office of Science, Center for Tobacco Products, U.S. Food and Drug Administration , Silver Spring, MD 20993
1 shared publication - Amanda Fidalgo
Center for Tobacco Products, Food and Drug Administration Silver Spring United States
1 shared publication - Brittany Merson
Center for Tobacco Products, Food and Drug Administration Silver Spring United States
1 shared publication - In Heon Lee
Office of Science, Center for Tobacco Products, U.S. Food and Drug Administration , Silver Spring, MD 20993
1 shared publication - Jennifer Kim Bernat
Indiana University School of Nursing, Indianapolis, IN
1 shared publication - Jessica K. Pepper
Center for Health Policy Science & Tobacco Research, RTI International, Research Triangle Park, NC
1 shared publication
Latest Publications
- Open Access
- 17 April 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (9) , 1599-1603
Sales of cigarettes with WS-3, a synthetic cooling agent, in an area with a menthol cigarette sales prohibition
Introduction: The synthetic cooling agent WS-3 (N-ethyl-p-menthane-3-carboxamide) elicits a cooling sensation without a minty taste. In areas with menthol cigarette sales prohibitions, such as California, tobacco companies have marketed cigarettes with WS-3 as alternatives to menthol cigarettes. We examined sales of cigarettes with WS-3 in NielsenIQ’s Retail Measurement Services Pacific division, which includes the state of California. Methods: With NielsenIQ data, we estimated sales of cigarettes with WS-3 from June 2022 to March 2024. We compared the NielsenIQ Pacific division, which includes California and two less populous states (Washington and Oregon), to all other divisions combined. Within the Pacific division, we compared trends in sales of cigarettes with WS-3 to menthol cigarettes. Results: In our study period, cigarettes with WS-3 appeared in the NielsenIQ Pacific division approximately 2 weeks before the implementation of California’s menthol cigarette prohibition in December 2022 and did not appear elsewhere in substantive quantities (>5 cartons) until Spring 2023. Most (87.0%) sales of cigarettes with WS-3 during the study period occurred in the Pacific division, peaking near 19 000 weekly carton sales. Weekly sales of Pacific division menthol cigarettes dropped by more than 100 000 cartons in 2 months after California’s prohibition. Conclusion: In the Pacific division, California’s menthol cigarette prohibition appears to have moderately reduced sales of menthol cigarettes and spurred sales of cigarettes with WS-3. Observationally, these sales data suggest that cigarettes with WS-3 only partially displaced the declining sales of menthol cigarettes. Future research could examine reasons for and experiences using cigarettes with WS-3. Implications: Tobacco companies explicitly marketed cigarettes with the synthetic cooling agent WS-3 as replacements for menthol cigarettes. Sales data from NielsenIQ’s Pacific division suggest that California’s menthol cigarette prohibition may have reduced sales of menthol cigarettes and spurred the introduction of cigarettes with WS-3 into the marketplace. The findings suggest that sales of cigarettes with WS-3 did not fully offset the decrease in menthol cigarette sales.
- 17 April 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (9) , 1599-1603
Open AccessSales of cigarettes with WS-3, a synthetic cooling agent, in an area with a menthol cigarette sales prohibition
Introduction: The synthetic cooling agent WS-3 (N-ethyl-p-menthane-3-carboxamide) elicits a cooling sensation without a minty taste. In areas with menthol cigarette sales prohibitions, such as California, tobacco companies have marketed cigarettes with WS-3 as alternatives to menthol cigarettes. We examined sales of cigarettes with WS-3 in NielsenIQ’s Retail Measurement Services Pacific division, which includes the state of California. Methods: With NielsenIQ data, we estimated sales of cigarettes with WS-3 from June 2022 to March 2024. We compared the NielsenIQ Pacific division, which includes California and two less populous states (Washington and Oregon), to all other divisions combined. Within the Pacific division, we compared trends in sales of cigarettes with WS-3 to menthol cigarettes. Results: In our study period, cigarettes with WS-3 appeared in the NielsenIQ Pacific division approximately 2 weeks before the implementation of California’s menthol cigarette prohibition in December 2022 and did not appear elsewhere in substantive quantities (>5 cartons) until Spring 2023. Most (87.0%) sales of cigarettes with WS-3 during the study period occurred in the Pacific division, peaking near 19 000 weekly carton sales. Weekly sales of Pacific division menthol cigarettes dropped by more than 100 000 cartons in 2 months after California’s prohibition. Conclusion: In the Pacific division, California’s menthol cigarette prohibition appears to have moderately reduced sales of menthol cigarettes and spurred sales of cigarettes with WS-3. Observationally, these sales data suggest that cigarettes with WS-3 only partially displaced the declining sales of menthol cigarettes. Future research could examine reasons for and experiences using cigarettes with WS-3. Implications: Tobacco companies explicitly marketed cigarettes with the synthetic cooling agent WS-3 as replacements for menthol cigarettes. Sales data from NielsenIQ’s Pacific division suggest that California’s menthol cigarette prohibition may have reduced sales of menthol cigarettes and spurred the introduction of cigarettes with WS-3 into the marketplace. The findings suggest that sales of cigarettes with WS-3 did not fully offset the decrease in menthol cigarette sales.
- Open Access
- 16 January 2026
- Published by European Publishing in Tobacco Induced Diseases
- Vol. 24 (January) , 1-6
Perceptions of nicotine harm among adults who use little cigars and cigarillos: A cross-sectional analysis of wave 7 of the Population Assessment of Tobacco and Health (PATH) Study 2022–2023
Introduction: Little is known about nicotine perceptions among people who use little cigars and cigarillos (LCCs). Nicotine perceptions may influence how people respond to changes in the tobacco marketplace, including changes that would result from regulatory actions such as a proposed nicotine...
- 16 January 2026
- Published by European Publishing in Tobacco Induced Diseases
- Vol. 24 (January) , 1-6
Open AccessPerceptions of nicotine harm among adults who use little cigars and cigarillos: A cross-sectional analysis of wave 7 of the Population Assessment of Tobacco and Health (PATH) Study 2022–2023
Introduction: Little is known about nicotine perceptions among people who use little cigars and cigarillos (LCCs). Nicotine perceptions may influence how people respond to changes in the tobacco marketplace, including changes that would result from regulatory actions such as a proposed nicotine...